121 related articles for article (PubMed ID: 22826848)
1. [IRIDA: what's new].
Nafil H; Tazi I; Mahmal L
Ann Biol Clin (Paris); 2012; 70(3):359-60. PubMed ID: 22826848
[No Abstract] [Full Text] [Related]
2. Haematologic data, iron parameters and molecular findings in two new cases of iron-refractory iron deficiency anaemia.
Tchou I; Diepold M; Pilotto PA; Swinkels D; Neerman-Arbez M; Beris P
Eur J Haematol; 2009 Dec; 83(6):595-602. PubMed ID: 19708871
[TBL] [Abstract][Full Text] [Related]
3. Iron-refractory iron deficiency anemia (IRIDA) cases with 2 novel TMPRSS6 mutations.
Sal E; Keskin EY; Yenicesu I; Bruno M; De Falco L
Pediatr Hematol Oncol; 2016 Apr; 33(3):226-32. PubMed ID: 27120435
[TBL] [Abstract][Full Text] [Related]
4. Responsiveness to oral iron and ascorbic acid in a patient with IRIDA.
Cau M; Galanello R; Giagu N; Melis MA
Blood Cells Mol Dis; 2012 Feb; 48(2):121-3. PubMed ID: 22169218
[TBL] [Abstract][Full Text] [Related]
5. [Identification and characterization of clinical features and gene mutation in a patient with iron refractory iron deficiency anemia (IRIDA)].
Xiong Y; Yang W; Li Y; Peng G; Li Y; Fan H; Ye L; Song L; Zhao X; Li J; Jing L; Zhang L; Zhou K; Xu Y; Zhang F
Zhonghua Xue Ye Xue Za Zhi; 2014 Jun; 35(6):486-90. PubMed ID: 24985168
[TBL] [Abstract][Full Text] [Related]
6. Is the acronym IRIDA acceptable for slow responders to iron in the presence of TMPRSS6 mutations?
Yilmaz-Keskin E; Sal E; de Falco L; Bruno M; Iolascon A; Koçak U; Yenicesu I
Turk J Pediatr; 2013; 55(5):479-84. PubMed ID: 24382527
[TBL] [Abstract][Full Text] [Related]
7. Genetic variability of TMPRSS6 and its association with iron deficiency anaemia.
Delbini P; Vaja V; Graziadei G; Duca L; Nava I; Refaldi C; Cappellini MD
Br J Haematol; 2010 Nov; 151(3):281–4. PubMed ID: 20738301
[TBL] [Abstract][Full Text] [Related]
8. The role of Matriptase-2 during the early postnatal development in humans.
De Falco L; Bruno M; Yilmaz-Keskin E; Sal E; Büyükavci M; Kaya Z; Girelli D; Iolascon A
Haematologica; 2016 Apr; 101(4):e126-8. PubMed ID: 26802052
[No Abstract] [Full Text] [Related]
9. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA).
Finberg KE; Heeney MM; Campagna DR; Aydinok Y; Pearson HA; Hartman KR; Mayo MM; Samuel SM; Strouse JJ; Markianos K; Andrews NC; Fleming MD
Nat Genet; 2008 May; 40(5):569-71. PubMed ID: 18408718
[TBL] [Abstract][Full Text] [Related]
10. Functional and clinical impact of novel TMPRSS6 variants in iron-refractory iron-deficiency anemia patients and genotype-phenotype studies.
De Falco L; Silvestri L; Kannengiesser C; Morán E; Oudin C; Rausa M; Bruno M; Aranda J; Argiles B; Yenicesu I; Falcon-Rodriguez M; Yilmaz-Keskin E; Kocak U; Beaumont C; Camaschella C; Iolascon A; Grandchamp B; Sanchez M
Hum Mutat; 2014 Nov; 35(11):1321-9. PubMed ID: 25156943
[TBL] [Abstract][Full Text] [Related]
11. Two novel mutations in the tmprss6 gene associated with iron-refractory iron-deficiency anaemia (irida) and partial expression in the heterozygous form.
Pellegrino RM; Coutinho M; D'Ascola D; Lopes AM; Palmieri A; Carnuccio F; Costa M; Zecchina G; Saglio G; Costa E; Barbot J; Porto G; Pinto JP; Roetto A
Br J Haematol; 2012 Sep; 158(5):668-72. PubMed ID: 22765023
[No Abstract] [Full Text] [Related]
12. Into the matrix: regulation of the iron regulatory hormone hepcidin by matriptase-2.
Knutson MD
Nutr Rev; 2009 May; 67(5):284-8. PubMed ID: 19386032
[TBL] [Abstract][Full Text] [Related]
13. Iron-refractory iron deficiency anemia.
Finberg KE
Semin Hematol; 2009 Oct; 46(4):378-86. PubMed ID: 19786206
[TBL] [Abstract][Full Text] [Related]
14. A child with severe iron-deficiency anemia and a complex TMPRSS6 genotype.
Capra AP; Ferro E; Cannavò L; La Rosa MA; Zirilli G
Hematology; 2017 Oct; 22(9):559-564. PubMed ID: 28447549
[TBL] [Abstract][Full Text] [Related]
15. A novel mutation in the CUB sequence of matriptase-2 (TMPRSS6) is implicated in iron-resistant iron deficiency anaemia (IRIDA).
Jaspers A; Caers J; Le Gac G; Ferec C; Beguin Y; Fillet G
Br J Haematol; 2013 Feb; 160(4):564-5. PubMed ID: 23216605
[No Abstract] [Full Text] [Related]
16. Administration of recombinant erythropoietin alone does not improve the phenotype in iron refractory iron deficiency anemia patients.
Lehmberg K; Grosse R; Muckenthaler MU; Altamura S; Nielsen P; Schmid H; Graubner U; Oyen F; Zeller W; Schneppenheim R; Janka GE
Ann Hematol; 2013 Mar; 92(3):387-94. PubMed ID: 23180434
[TBL] [Abstract][Full Text] [Related]
17. Matriptase-2 mutations in iron-refractory iron deficiency anemia patients provide new insights into protease activation mechanisms.
Ramsay AJ; Quesada V; Sanchez M; Garabaya C; Sardà MP; Baiget M; Remacha A; Velasco G; López-Otín C
Hum Mol Genet; 2009 Oct; 18(19):3673-83. PubMed ID: 19592582
[TBL] [Abstract][Full Text] [Related]
18. A new form of IRIDA due to combined heterozygous mutations of
Pagani A; Colucci S; Bocciardi R; Bertamino M; Dufour C; Ravazzolo R; Silvestri L; Camaschella C
Blood; 2017 Jun; 129(25):3392-3395. PubMed ID: 28476747
[No Abstract] [Full Text] [Related]
19. Normalizing hepcidin predicts
Heeney MM; Guo D; De Falco L; Campagna DR; Olbina G; Kao PP; Schmitz-Abe K; Rahimov F; Gutschow P; Westerman K; Ostland V; Jackson T; Klaassen RJ; Markianos K; Finberg KE; Iolascon A; Westerman M; London WB; Fleming MD
Blood; 2018 Jul; 132(4):448-452. PubMed ID: 29895660
[No Abstract] [Full Text] [Related]
20. Iron Refractory Iron Deficiency Anaemia: A Rare Cause of Iron Deficiency Anaemia.
McGrath T; Cotter M
Ir Med J; 2018 Jan; 111(1):678. PubMed ID: 29869859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
